FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149100164> ?p ?o ?g. }

• W2149100164 endingPage "534" @default.
• W2149100164 startingPage "527" @default.
• W2149100164 abstract "To assess the performance capabilities of multiparametric magnetic resonance imaging (mpMRI), the prostate health index (PHI) and prostate cancer antigen 3 (PCA3) in predicting the presence of pathologically confirmed significant prostate cancer (PCSPCa), according to the European Randomized Study of Screening Prostate Cancer definition, in a single cohort of patients who underwent radical prostatectomy (RP) but who were eligible for active surveillance (AS).An observational retrospective study was performed in 120 patients with prostate cancer (PCa), treated with robot-assisted RP but eligible for AS according to Prostate Cancer Research International: Active Surveillance criteria. Blood and urine specimens were collected before initial prostate biopsy for PHI and PCA3 measurements, respectively. In addition, all patients underwent mpMRI, preoperatively and 6-8 weeks after biopsy, with a 1.5T scanner using a four-to-five-channel phase array coil combined with an endorectal coin. mpMRI images were assessed and diagrams showing the prostate sextants were used to designate regions of abnormality within the prostate. Prostate findings were assigned to one of five categories according to Prostate Imaging-Reporting and Data System guidelines (PI-RADS) and considered positive for PCa if final PI-RADS score was >3 and negative if ≤3.Pathologically confirmed reclassification was observed in 55 patients (45.8%). mpMRI showed good specificity and negative predictive value (0.61 and 0.73, respectively) for excluding PCSPCa compared with the PHI and PCA3. On multivariate analyses and after 1 000 bootstrapping resampling, the inclusion of both mpMRI and the PHI significantly increased the accuracy of the base model in predicting PCSPCa. For the prediction of PCSPCa, in particular, the base model had an area under the curve (AUC) of 0.71 which significantly increased by 4% with the addition of the PHI (AUC = 0.75; P < 0.01) and by 7% with the addition of mpMRI (AUC = 0.78; P < 0.01). Decision-curve analysis showed that the multivariable model with mpMRI had the highest net benefit.In a single cohort of patients who underwent RP but who were eligible for AS, mpMRI and, to a lesser extent, the PHI, had an important role in discriminating the presence of PCSPCa; both measures could therefore be useful in the selection and monitoring of patients undergoing AS." @default.
• W2149100164 created "2016-06-24" @default.
• W2149100164 creator A5002977464 @default.
• W2149100164 creator A5004551774 @default.
• W2149100164 creator A5013771798 @default.
• W2149100164 creator A5038137057 @default.
• W2149100164 creator A5040694356 @default.
• W2149100164 creator A5070965901 @default.
• W2149100164 creator A5079727252 @default.
• W2149100164 creator A5083745890 @default.
• W2149100164 date "2015-10-12" @default.
• W2149100164 modified "2023-10-04" @default.
• W2149100164 title "In-parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance" @default.
• W2149100164 cites W1512405047 @default.
• W2149100164 cites W1516346188 @default.
• W2149100164 cites W1523932244 @default.
• W2149100164 cites W1568681957 @default.
• W2149100164 cites W1976116238 @default.
• W2149100164 cites W1993704614 @default.
• W2149100164 cites W2000977941 @default.
• W2149100164 cites W2003295161 @default.
• W2149100164 cites W2023922025 @default.
• W2149100164 cites W2028569476 @default.
• W2149100164 cites W2029481107 @default.
• W2149100164 cites W2045030989 @default.
• W2149100164 cites W2059619755 @default.
• W2149100164 cites W2064134045 @default.
• W2149100164 cites W2064240815 @default.
• W2149100164 cites W2070349594 @default.
• W2149100164 cites W2073970180 @default.
• W2149100164 cites W2083043726 @default.
• W2149100164 cites W2091854605 @default.
• W2149100164 cites W2096004364 @default.
• W2149100164 cites W2101373837 @default.
• W2149100164 cites W2106869018 @default.
• W2149100164 cites W2111288468 @default.
• W2149100164 cites W2115895082 @default.
• W2149100164 cites W2119944369 @default.
• W2149100164 cites W2121655616 @default.
• W2149100164 cites W2124539070 @default.
• W2149100164 cites W2131241259 @default.
• W2149100164 cites W2131988302 @default.
• W2149100164 cites W2141198296 @default.
• W2149100164 cites W2145567935 @default.
• W2149100164 cites W2151929761 @default.
• W2149100164 cites W2157996158 @default.
• W2149100164 cites W2168661851 @default.
• W2149100164 doi "https://doi.org/10.1111/bju.13318" @default.
• W2149100164 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26350955" @default.
• W2149100164 hasPublicationYear "2015" @default.
• W2149100164 type Work @default.
• W2149100164 sameAs 2149100164 @default.
• W2149100164 citedByCount "36" @default.
• W2149100164 countsByYear W21491001642016 @default.
• W2149100164 countsByYear W21491001642017 @default.
• W2149100164 countsByYear W21491001642018 @default.
• W2149100164 countsByYear W21491001642019 @default.
• W2149100164 countsByYear W21491001642020 @default.
• W2149100164 countsByYear W21491001642021 @default.
• W2149100164 countsByYear W21491001642022 @default.
• W2149100164 crossrefType "journal-article" @default.
• W2149100164 hasAuthorship W2149100164A5002977464 @default.
• W2149100164 hasAuthorship W2149100164A5004551774 @default.
• W2149100164 hasAuthorship W2149100164A5013771798 @default.
• W2149100164 hasAuthorship W2149100164A5038137057 @default.
• W2149100164 hasAuthorship W2149100164A5040694356 @default.
• W2149100164 hasAuthorship W2149100164A5070965901 @default.
• W2149100164 hasAuthorship W2149100164A5079727252 @default.
• W2149100164 hasAuthorship W2149100164A5083745890 @default.
• W2149100164 hasBestOaLocation W21491001641 @default.
• W2149100164 hasConcept C121608353 @default.
• W2149100164 hasConcept C126322002 @default.
• W2149100164 hasConcept C126838900 @default.
• W2149100164 hasConcept C126894567 @default.
• W2149100164 hasConcept C143409427 @default.
• W2149100164 hasConcept C2775934546 @default.
• W2149100164 hasConcept C2776235491 @default.
• W2149100164 hasConcept C2779466945 @default.
• W2149100164 hasConcept C2780101318 @default.
• W2149100164 hasConcept C2780192828 @default.
• W2149100164 hasConcept C2781406297 @default.
• W2149100164 hasConcept C71924100 @default.
• W2149100164 hasConceptScore W2149100164C121608353 @default.
• W2149100164 hasConceptScore W2149100164C126322002 @default.
• W2149100164 hasConceptScore W2149100164C126838900 @default.
• W2149100164 hasConceptScore W2149100164C126894567 @default.
• W2149100164 hasConceptScore W2149100164C143409427 @default.
• W2149100164 hasConceptScore W2149100164C2775934546 @default.
• W2149100164 hasConceptScore W2149100164C2776235491 @default.
• W2149100164 hasConceptScore W2149100164C2779466945 @default.
• W2149100164 hasConceptScore W2149100164C2780101318 @default.
• W2149100164 hasConceptScore W2149100164C2780192828 @default.
• W2149100164 hasConceptScore W2149100164C2781406297 @default.
• W2149100164 hasConceptScore W2149100164C71924100 @default.
• W2149100164 hasIssue "4" @default.
• W2149100164 hasLocation W21491001641 @default.
• W2149100164 hasLocation W21491001642 @default.
• W2149100164 hasLocation W21491001643 @default.

• next